Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Aug;108(2 Suppl):43S-52S.
doi: 10.1378/chest.108.2_supplement.43s.

Epidemiology and treatment of chronic bronchitis and its exacerbations

P Ball  1
Affiliations
Review

Epidemiology and treatment of chronic bronchitis and its exacerbations

P Ball. Chest. 1995 Aug.
No abstract available

PubMed Disclaimer

Figures

F<sc>igure</sc> 1
Figure 1
Death rates per 100,000 population: adults aged 55 to 65, 1983.
F<sc>igure</sc> 2
Figure 2
Ratios of antibiotic concentrations in the bronchial mucosa to the MIC 90 (mg/L) of H influenzae (MICs are given in parentheses: kinetic data from Table 4).
F<sc>igure</sc> 3
Figure 3
Ratios of antibiotic concentrations in the bronchial mucosa to the MIC 90 (mg/L) of S pneumoniae (MICs are given in parentheses: kinetic data from Table 4).
See this image and copyright information in PMC

References

    1. Badham C. Observations on the inflammatory affections of the mucous membranes of the bronchiae. London, 1808
    1. Report (College of General Practitioners) Chronic bronchitis in Great Britain. BMJ. 1961;2:973.
    1. Garibaldi RA. Epidemiology of community acquired respiratory infections in adults. Am J Med. 1985;78(suppl 6B):32–37. - PMC - PubMed
    1. Balter MS, Hyland RH, Low DE. Recommendations on the management of chronic bronchitis: a practical guide for Canadian physicians. Can Med Assoc J. 1994;151:1–23.
    1. Woolcock AJ. Epidemiology of chronic airways disease. Chest. 1989;96(suppl):302S–306S. - PubMed

Uncited references

    1. Allegra L, Brumpt I. Programme and Abstracts, 5th International Symposium of New Quinolones, Singapore: August 1994. Sparfloxacin (S) in the management of acute exacerbations of chronic obstructive pulmonary disease (COPD): a comparison with Augmentin (abstract 139).
    1. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalised for community acquired pneumonia. Ann Intern Med. 1991;115:429–443. - PubMed
    1. Niederman MS, Bass JB, Campbell GD. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis. 1993;148:1418–1426. - PubMed
    1. Lindsay G, Scorer HJN, Carnegie CMD. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomised, double-blind trial. J Antimicrob Chemother. 1992;30:89–100. - PubMed
    1. Nicotra MB, Rivera M, Awe RJ. Antibiotic therapy of acute exacerbations of chronic bronchitis: a controlled study using tetracycline. Ann Intern Med. 1982;97:18–21. - PubMed